2017
DOI: 10.1016/j.elecom.2017.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Voltammetric signatures of 2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamines on boron-doped diamond electrodes: Detection in blotting paper samples

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 11 publications
0
8
0
3
Order By: Relevance
“…NBOMe Compounds: 2016 The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography [ 1021 ]; case series: toxicity from 25B–NBOMe--a cluster of N-bomb cases [ 1022 ]; HPTLC and GC-MS analysis of 25 C NBOMe in Seized Blotters [ 1023 ]; Detection of 25C–NBOMe using LC-QTOF designer drug screen and quantitated by LC-MS-MS [ 1024 ]; identification of 2,4,6-TMPEA-NBOMe by GC-MS, GC-HRMS, GC-HRMS/MS, UHPLC/HRMS, UHPLC/HRMS/MS, and (1) H and (13) C NMR [ 1025 ]; analytical characterization of 3,4-DMA-NBOMe (1), 4-EA-NBOMe (2), 4-MMA-NBOMe (3), and 5-APB-NBOMe (4) by MS, IR spectroscopic, and NMR spectroscopic data [ 1026 ]; chemical profiling of 25I–NBOMe TLC, UV–Vis, ATR-FTIR, GC-MS and ESI-FT-ICR MS [ 1027 ]; identification of 25X-NBOMe and analogues by GC-MS [ 1028 ]; 2017 Rapid screening and analytical determination of 25B–NBOMe and 25I–NBOMe via Cyclic and Differential Pulse Voltammetry [ 1029 ]; 25B–NBOMe and 25C–NBOMe by GC-MS, LC-MS(n), and LC-HR-MS/MS [ 1030 ]; Identification and quantification of 5 different 25-NBOMes (25B–NBOMe, 25C–NBOMe, 25D-NBOMe, 25H–NBOMe, 25I–NBOMe) via LC-MS-MS [ 1031 ]; synthesis of potential metabolites of 25C–NBOMe and 25I–NBOMe [ 1032 ]; UPLC-QTOF-MS analysis of twelve 2C-X, six 2,5-dimethoxyamphetamines (DOX), and fourteen 25X-NBOMe derivatives, including two deuterated derivatives (2C–B-d(6) and 25I–NBOMe-d(9) [ 1033 ]; identification of NBOMes and the analogous 2,5-dimethoxy phenethylamine structures by voltammetric methods in blotting paper seized from the drug market [ 1034 ]; modification of solvent delay window to prevent misidentification of 25I–NBOH as 2C–I with GC-MS [ 1035 ]; 25c-nbome: Case report and literature review [ 1036 ]; comparison of nano-LC-HRMS/MS to UHPLC for detection of 3,4-DMA-NBOMe and 4-MMA-NBOMe and metabolites [ 1037 ]; 2018 square-wave voltammetry for the quantification of NBOMes and their correlates, 2,5-dimethoxy phenethylamine structures in seized blotting paper [ 1038 ]; the analysis of illicit 25X-NBOMe from over 100 seizures in Western Australia [ 1039 ] ; LC-HR-MS/MS identification of the phase I and II metabolites of 4-EA-NBOMe [ 1040 ]; LC-MS-MS confirmation of 251-NBOMe [ 1041 ]; 2019 handheld NIR spectrometer for discrimination of NBOMe and NBOH drugs absorbed in blotter papers using PLS-DA and SIMCA [ 1042 ]; 2019 SPCE electrochemical method for the detection of 25I–NBOH and full differentiation between 25I–NBOH, 2C–I and 25I–NBOMe [ 1043 ]; review [ 1044 ]; review of the main methods for the analysis of NBOMe compounds for detection in seized and biological materials for forensic a...…”
Section: Routine and Improved Analyses Of Abused Substancesmentioning
confidence: 99%
“…NBOMe Compounds: 2016 The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography [ 1021 ]; case series: toxicity from 25B–NBOMe--a cluster of N-bomb cases [ 1022 ]; HPTLC and GC-MS analysis of 25 C NBOMe in Seized Blotters [ 1023 ]; Detection of 25C–NBOMe using LC-QTOF designer drug screen and quantitated by LC-MS-MS [ 1024 ]; identification of 2,4,6-TMPEA-NBOMe by GC-MS, GC-HRMS, GC-HRMS/MS, UHPLC/HRMS, UHPLC/HRMS/MS, and (1) H and (13) C NMR [ 1025 ]; analytical characterization of 3,4-DMA-NBOMe (1), 4-EA-NBOMe (2), 4-MMA-NBOMe (3), and 5-APB-NBOMe (4) by MS, IR spectroscopic, and NMR spectroscopic data [ 1026 ]; chemical profiling of 25I–NBOMe TLC, UV–Vis, ATR-FTIR, GC-MS and ESI-FT-ICR MS [ 1027 ]; identification of 25X-NBOMe and analogues by GC-MS [ 1028 ]; 2017 Rapid screening and analytical determination of 25B–NBOMe and 25I–NBOMe via Cyclic and Differential Pulse Voltammetry [ 1029 ]; 25B–NBOMe and 25C–NBOMe by GC-MS, LC-MS(n), and LC-HR-MS/MS [ 1030 ]; Identification and quantification of 5 different 25-NBOMes (25B–NBOMe, 25C–NBOMe, 25D-NBOMe, 25H–NBOMe, 25I–NBOMe) via LC-MS-MS [ 1031 ]; synthesis of potential metabolites of 25C–NBOMe and 25I–NBOMe [ 1032 ]; UPLC-QTOF-MS analysis of twelve 2C-X, six 2,5-dimethoxyamphetamines (DOX), and fourteen 25X-NBOMe derivatives, including two deuterated derivatives (2C–B-d(6) and 25I–NBOMe-d(9) [ 1033 ]; identification of NBOMes and the analogous 2,5-dimethoxy phenethylamine structures by voltammetric methods in blotting paper seized from the drug market [ 1034 ]; modification of solvent delay window to prevent misidentification of 25I–NBOH as 2C–I with GC-MS [ 1035 ]; 25c-nbome: Case report and literature review [ 1036 ]; comparison of nano-LC-HRMS/MS to UHPLC for detection of 3,4-DMA-NBOMe and 4-MMA-NBOMe and metabolites [ 1037 ]; 2018 square-wave voltammetry for the quantification of NBOMes and their correlates, 2,5-dimethoxy phenethylamine structures in seized blotting paper [ 1038 ]; the analysis of illicit 25X-NBOMe from over 100 seizures in Western Australia [ 1039 ] ; LC-HR-MS/MS identification of the phase I and II metabolites of 4-EA-NBOMe [ 1040 ]; LC-MS-MS confirmation of 251-NBOMe [ 1041 ]; 2019 handheld NIR spectrometer for discrimination of NBOMe and NBOH drugs absorbed in blotter papers using PLS-DA and SIMCA [ 1042 ]; 2019 SPCE electrochemical method for the detection of 25I–NBOH and full differentiation between 25I–NBOH, 2C–I and 25I–NBOMe [ 1043 ]; review [ 1044 ]; review of the main methods for the analysis of NBOMe compounds for detection in seized and biological materials for forensic a...…”
Section: Routine and Improved Analyses Of Abused Substancesmentioning
confidence: 99%
“…Together with usual difficulties associated with the identification of NPS (unknown substance, never before reported, not present in reference spectral libraries, no certified standards available, etc), detection of NBOHs present yet another important trait: thermal degradation under standard gas chromatography, which seriously increases the risk of misidentification [15,16] and demands the development of other detection methods [17][18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…The electroanalytical methods have had a great emphasis in recent years because of their portability and other advantages, which permit on‐site and in situ analyses with applicability in several areas of knowledge . These methods mainly stand out for their high sensitivity, rapidity, low‐cost, simplicity of application and fewer (or lack of) sample pretreatment steps .…”
Section: Introductionmentioning
confidence: 99%